iiinova — where your digital self keeps evolving

Reposted by Srishti Patil

Rob Noble @robjohnnoble.bsky.social · 22/05/2026

Great to have @srishtipatil.bsky.social presenting her new research on early-onset tumours, here at ISEEC 2026. Tomorrow I'll be talking about her previous work with me

083

Reposted by Srishti Patil

Chaitanya Gokhale @gokhalecs.bsky.social · 12/03/2026

Fantastic double feature seminar today by @sabinenoebel.bsky.social on tradition, culture and mate copying in #drosophila and a superb theory study of the same by @srishtipatil.bsky.social ! It’s been a pleasure hosting you both here @cctb-wue.bsky.social @uni-wuerzburg.de

0104

Reposted by Srishti Patil

Genetics Society of America @genetics-gsa.bsky.social · 03/02/2026

In #GENETICS, @srishtipatil.bsky.social, @robjohnnoble.bsky.social, and colleagues present a theoretical framework to determine how to exploit the vulnerability of small tumours to stochastic extinction and the optimal time to switch treatments. buff.ly/HDhvCEN

143

Reposted by Srishti Patil

Rob Noble @robjohnnoble.bsky.social · 29/11/2025

Now free to read in Genetics (@genetics-gsa.bsky.social): "Preventing evolutionary rescue in cancer using two-strike therapy" #mathonco study by @srishtipatil.bsky.social, @armaanahmed.bsky.social, Yannick Viossat and me, determining the optimal time to switch treatments. doi.org/10.1093/gene...

doi.org

Preventing evolutionary rescue in cancer using two-strike therapy

Abstract. First-line cancer treatment frequently fails due to initially rare therapeutic resistance. An important clinical question is then how to schedule

2157

Reposted by Srishti Patil

Dan Schrider @samurscicop.bsky.social · 17/01/2025

In the latest from the lab (www.biorxiv.org/content/10.1...), PhD student Amjad Dabi used simulation to investigate the emergence of resistance to therapy in cancer under an evolutionary rescue model. Why does treatment for some cancers fail after a period of initial effectiveness? (1/n)

biorxiv.org

Evolutionary rescue model informs strategies for driving cancer cell populations to extinction

Cancers exhibit a remarkable ability to develop resistance to a range of treatments, often resulting in relapse following first-line therapies and significantly worse outcomes for subsequent treatment...

254